RxDoctor Payments Data

Sophia Stefano, APRN

Family · Brandon, FLNPI 1508361619

Payments from drug & device makers

$463in general payments, 2019–2025

Across 23 payments — averaging $20.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$121
  • Lilly USA, LLC$94
  • Pfizer$65
  • Novo Nordisk$45
  • Boston Scientific$29
  • Astellas Pharma US Inc$25
  • plus $84 from 5 others

What the payments were for

  • Food & beverage$463100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$463 in reported general payments places this provider in the 55th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$65,521
Medicare patients
175
Services billed
1,398

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol12$15,931
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,296
Atorvastatin Calcium119$1,047
Levothyroxine Sodium86$855
Rosuvastatin Calcium73$854
Lisinopril99$615
Metoprolol Succinate40$598
Tamsulosin Hcl34$571
Valsartan14$554
Albuterol Sulfate HfaAlbuterol Sulfate18$459
Losartan Potassium58$447
Amlodipine Besylate43$325
Famotidine36$312
Escitalopram Oxalate21$287
Montelukast Sodium21$277

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$14$7,29611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 14,618 family providers in Florida.

Other family in Brandon

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →